Expect mergers and acquisition action, albeit for “smaller assets,” by Dr. Reddy's Laboratories Ltd. - the front-line Indian firm appears set to seal a deal or so sometime soon, if all goes per plan, going by senior management commentary at its fiscal third quarter earnings announcement.
Acquisitions, Mix-Match Sputnik Light Booster On Dr Reddy’s Menu
Dr Reddy’s indicates it is actively pursuing acquisitions, likely involving relatively smaller assets, across several key markets on the back of a “healthy” balance sheet. It is also progressing plans to position Russian COVID-19 vaccine Sputnik Light as a booster, which it believes could potentially be “part of life” hereon.
